Ionis Pharmaceuticals IONS Quick ratio
Quick ratio at other companies
Other financials
Where this comes from
Calculated from Ionis Pharmaceuticals’s reported figures.
Based on the most recent quarter.
The official record: Ionis Pharmaceuticals’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ionis Pharmaceuticals's quick ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ionis Pharmaceuticals's quick ratio?
- Ionis Pharmaceuticals (IONS) reported quick ratio of 4.1× in Q1 2026.
- How has Ionis Pharmaceuticals's quick ratio changed year-over-year?
- Ionis Pharmaceuticals's quick ratio decreased by 57.5% year-over-year, from 9.6× to 4.1×.
- What is the long-term trend for Ionis Pharmaceuticals's quick ratio?
- Over 5 years (2020 to 2025), Ionis Pharmaceuticals's quick ratio has grown at a 1.6% compound annual growth rate (CAGR), from 3.5× to 3.8×.
- What does quick ratio mean?
- Can the company cover short-term bills without having to sell inventory first?
- How do you interpret quick ratio?
- More conservative than the current ratio. A wide gap between the two flags heavy reliance on inventory to meet near-term obligations.
- How does quick ratio compare across companies?
- Most informative for inventory-heavy businesses; converges with the current ratio for firms that carry little inventory.